← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

▼ SELL

$ Value

$208K

Shares

1,000

Price

$208

Filed

Mar 25

Insider

Name

Sabba Stephen L

Title

CIK

0001442372

Roles

Director

Transaction Details

Transaction Date

2026-03-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

32,793

Footnotes

These securities, as represented in Column 5, include a grant of 1,209 restricted shares approved by the Board of Directors of the Company at the 2025 Meeting held 6 June 2025, which shares were previously reported on a Form 4 for this Reporting Person dated 10 June 2025, and are included on this Form 4 only to report that they will vest in full within six (6) months from the date hereof. | The price, as represented in Column 4, represents an average price per share of the following transactions on 23 March 2026: 100 shares at $208.055000, 17 shares at $207.980000, and 883 shares at $207.850000.

Filing Info

Accession No.

0001104659-26-034308

Form Type

4

Issuer CIK

0000886163

Sabba Stephen L's History

Date Ticker Type Value
2026-03-23 LGND $208K
2025-06-06 LGND A $0
2025-06-06 LGND A $0

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $94K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01